263 related articles for article (PubMed ID: 11058590)
1. Hyaluronidase induction of a WW domain-containing oxidoreductase that enhances tumor necrosis factor cytotoxicity.
Chang NS; Pratt N; Heath J; Schultz L; Sleve D; Carey GB; Zevotek N
J Biol Chem; 2001 Feb; 276(5):3361-70. PubMed ID: 11058590
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta1 blocks the enhancement of tumor necrosis factor cytotoxicity by hyaluronidase Hyal-2 in L929 fibroblasts.
Chang NS
BMC Cell Biol; 2002 Apr; 3():8. PubMed ID: 11960552
[TBL] [Abstract][Full Text] [Related]
3. WOX1 is essential for tumor necrosis factor-, UV light-, staurosporine-, and p53-mediated cell death, and its tyrosine 33-phosphorylated form binds and stabilizes serine 46-phosphorylated p53.
Chang NS; Doherty J; Ensign A; Schultz L; Hsu LJ; Hong Q
J Biol Chem; 2005 Dec; 280(52):43100-8. PubMed ID: 16219768
[TBL] [Abstract][Full Text] [Related]
4. JNK1 physically interacts with WW domain-containing oxidoreductase (WOX1) and inhibits WOX1-mediated apoptosis.
Chang NS; Doherty J; Ensign A
J Biol Chem; 2003 Mar; 278(11):9195-202. PubMed ID: 12514174
[TBL] [Abstract][Full Text] [Related]
5. Zfra affects TNF-mediated cell death by interacting with death domain protein TRADD and negatively regulates the activation of NF-kappaB, JNK1, p53 and WOX1 during stress response.
Hong Q; Hsu LJ; Schultz L; Pratt N; Mattison J; Chang NS
BMC Mol Biol; 2007 Jun; 8():50. PubMed ID: 17567906
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of WW domain-containing oxidoreductase WOX1 preferentially induces apoptosis in human glioblastoma cells harboring mutant p53.
Chiang MF; Yeh ST; Liao HF; Chang NS; Chen YJ
Biomed Pharmacother; 2012 Sep; 66(6):433-8. PubMed ID: 22898080
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms underlying WOX1 activation during apoptotic and stress responses.
Chang NS; Doherty J; Ensign A; Lewis J; Heath J; Schultz L; Chen ST; Oppermann U
Biochem Pharmacol; 2003 Oct; 66(8):1347-54. PubMed ID: 14555208
[TBL] [Abstract][Full Text] [Related]
8. Modulation of Sonic hedgehog signaling and WW domain containing oxidoreductase WOX1 expression enhances radiosensitivity of human glioblastoma cells.
Chiang MF; Chen HH; Chi CW; Sze CI; Hsu ML; Shieh HR; Lin CP; Tsai JT; Chen YJ
Exp Biol Med (Maywood); 2015 Mar; 240(3):392-9. PubMed ID: 25595187
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor beta1 signaling via interaction with cell surface Hyal-2 and recruitment of WWOX/WOX1.
Hsu LJ; Schultz L; Hong Q; Van Moer K; Heath J; Li MY; Lai FJ; Lin SR; Lee MH; Lo CP; Lin YS; Chen ST; Chang NS
J Biol Chem; 2009 Jun; 284(23):16049-59. PubMed ID: 19366691
[TBL] [Abstract][Full Text] [Related]
10. Zfra is an inhibitor of Bcl-2 expression and cytochrome c release from the mitochondria.
Hsu LJ; Hong Q; Schultz L; Kuo E; Lin SR; Lee MH; Lin YS; Chang NS
Cell Signal; 2008 Jul; 20(7):1303-12. PubMed ID: 18403180
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronidase induces murine L929 fibrosarcoma cells resistant to tumor necrosis factor and Fas cytotoxicity in the presence of actinomycin D.
Chang NS
Cell Biochem Biophys; 1995-1996; 27(2):109-32. PubMed ID: 9106395
[TBL] [Abstract][Full Text] [Related]
12. A potential role of p53 and WOX1 in mitochondrial apoptosis (review).
Chang NS
Int J Mol Med; 2002 Jan; 9(1):19-24. PubMed ID: 11744990
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of WW domain-containing oxidoreductase induces Tau phosphorylation in vitro. A potential role in Alzheimer's disease.
Sze CI; Su M; Pugazhenthi S; Jambal P; Hsu LJ; Heath J; Schultz L; Chang NS
J Biol Chem; 2004 Jul; 279(29):30498-506. PubMed ID: 15126504
[TBL] [Abstract][Full Text] [Related]
14. Zfra is a small wizard in the mitochondrial apoptosis.
Dudekula S; Lee MH; Hsu LJ; Chen SJ; Chang NS
Aging (Albany NY); 2010 Dec; 2(12):1023-9. PubMed ID: 21212468
[TBL] [Abstract][Full Text] [Related]
15. 17beta-Estradiol upregulates and activates WOX1/WWOXv1 and WOX2/WWOXv2 in vitro: potential role in cancerous progression of breast and prostate to a premetastatic state in vivo.
Chang NS; Schultz L; Hsu LJ; Lewis J; Su M; Sze CI
Oncogene; 2005 Jan; 24(4):714-23. PubMed ID: 15580310
[TBL] [Abstract][Full Text] [Related]
16. Characterization of an apoptosis inhibitory domain at the C-termini of FE65-like protein.
Cao H; Pratt N; Mattison J; Zhao Y; Chang NS
Biochem Biophys Res Commun; 2000 Oct; 276(3):843-50. PubMed ID: 11027557
[TBL] [Abstract][Full Text] [Related]
17. Complement C1q activates tumor suppressor WWOX to induce apoptosis in prostate cancer cells.
Hong Q; Sze CI; Lin SR; Lee MH; He RY; Schultz L; Chang JY; Chen SJ; Boackle RJ; Hsu LJ; Chang NS
PLoS One; 2009 Jun; 4(6):e5755. PubMed ID: 19484134
[TBL] [Abstract][Full Text] [Related]
18. The non-ankyrin C terminus of Ikappa Balpha physically interacts with p53 in vivo and dissociates in response to apoptotic stress, hypoxia, DNA damage, and transforming growth factor-beta 1-mediated growth suppression.
Chang NS
J Biol Chem; 2002 Mar; 277(12):10323-31. PubMed ID: 11799106
[TBL] [Abstract][Full Text] [Related]
19. p53 overexpression and downregulation of inter-alpha-inhibitor are associated with hyaluronidase enhancement of TNF cytotoxicity in L929 fibroblasts.
Chang NS; Carey G; Pratt N; Chu E; Ou M
Cancer Lett; 1998 Sep; 131(1):45-54. PubMed ID: 9839619
[TBL] [Abstract][Full Text] [Related]
20. TIAF1 self-aggregation in peritumor capsule formation, spontaneous activation of SMAD-responsive promoter in p53-deficient environment, and cell death.
Chang JY; Chiang MF; Lin SR; Lee MH; He H; Chou PY; Chen SJ; Chen YA; Yang LY; Lai FJ; Hsieh CC; Hsieh TH; Sheu HM; Sze CI; Chang NS
Cell Death Dis; 2012 Apr; 3(4):e302. PubMed ID: 22534828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
